The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Politics

Trump’s most vulnerable nominees RFK Jr, Tulsi Gabbard get back-to-back hearings

by admin January 27, 2025
January 27, 2025
Trump’s most vulnerable nominees RFK Jr, Tulsi Gabbard get back-to-back hearings

Two of President Donald Trump’s most vulnerable administration picks will get back-to-back confirmation hearings in the Senate this week. 

Robert F. Kennedy Jr., who Trump nominated to be Secretary of Health and Human Services (HHS), and former Democratic Rep. Tulsi Gabbard, whom he selected to be Director of National Intelligence (DNI), will have committee confirmation hearings on Wednesday and Thursday. 

On Wednesday, Kennedy will have his first hearing with the Senate Finance Committee, who will eventually vote on whether to advance his nomination to the full Senate. He will have an additional hearing on Thursday with the Senate Committee on Health, Education, Labor and Pensions (HELP), but that committee will not have a vote on the nomination. 

Gabbard’s hearing with the Senate Select Committee on Intelligence will take place Thursday morning. 

The two Trump picks were some of the more controversial administration selections. Both Kennedy and Gabbard are former Democrats with histories of policy positions that clash with what many Republican senators believe. 

At issue for lawmakers on both sides is Kennedy’s history of significant criticism of vaccines and vaccination programs. For some Republicans whose states have a large farming constituency, his positions on further regulating agriculture and food production have been cause for concern. 

Gabbard’s past policy stances as they relate to national security have given bipartisan lawmakers some reason for pause, since the role she is nominated for is critical to the nation’s safety and defense. 

Both of the nominees have taken steps to moderate themselves amid the confirmation process. Kennedy has pushed back on suggestions that he is ‘anti-vaccine’ and explained, ‘If vaccines are working for somebody, I’m not going to take them away.’

‘People ought to have choice, and that choice ought to be informed by the best information,’ he said in an interview with NBC News. ‘So I’m going to make sure scientific safety studies and efficacy are out there, and people can make individual assessments about whether that product is going to be good for them.’

Gabbard recently made a remarkable reversal on a controversial intelligence tool used by the government. And her choice to change her position on the Foreign Intelligence Surveillance Act’s (FISA) section 702 managed to win her the backing of a Republican senator on the intel committee that she will need to advance out of. 

Recently asked whether her change of heart on section 702 had earned his vote, Sen. James Lankford, R-Okla., said, ‘Yeah, I am, and that was a very important piece for me.’

While both nominees have gotten some necessary Republican backing in the relevant committees, not everyone has said whether they will vote to advance the selections. And even if they are voted out of the committees, they could still face an uphill battle to be confirmed by the full Senate. 

This post appeared first on FOX NEWS

previous post
Potash Fertilizers: What’s the Difference Between SOP and MOP?
next post
After raucous first week in office, Donald Trump to keep his foot on the gas

Related Posts

Biden’s autopen use questioned amid released audio from...

May 17, 2025

EXCLUSIVE: Nancy Mace targeted by Pennsylvania man arrested...

April 15, 2025

Trump team holds ‘constructive’ face-to-face nuclear talks with...

April 13, 2025

Booker delivers record Senate speech against Trump admin,...

April 2, 2025

SEE IT: Republicans reveal expectations for Elon Musk’s...

March 6, 2025

RFK Jr’s HHS to end routine COVID vaccine...

May 16, 2025

SCOOP: Freedom Caucus threatens to force vote on...

March 12, 2025

Trump FCC chair targets NPR, PBS for investigation...

January 31, 2025

Busy week ahead for Trump, Cabinet picks

February 3, 2025

Lawyer of whistleblower in Trump impeachment case sues...

May 6, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 4

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 5

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 6

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved